San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.
Celsius Quiz on National Cholesterol Awareness Month
A new study published in Nature Communications identifies the unique pathway that enhances the delivery of anti-cancer drugs to tumors.
San Diego’s Avalon Ventures is taking the wraps off two new startups today, with each one getting as much as $10 million in Series A financing through the partnership that Avalon established early…
[[Click headline to continue reading.]]
Professor Jack Johnson was nominated with 22 letters of support from current and former trainees.
The Boger lab has made a powerful analog of vancomycin that is effective against MRSA and other disease-causing bacteria.
On the occasion of positive new data for RPC1063, Professor Hugh Rosen shares his perspective on the drug candidate, which was initially discovered, synthesized and developed at TSRI.
“It has added power to many of the technologies we already have on campus,” says Professor Luc Teyton.
UCSD scientists found a twist in how bad news affects the brain, and depression therapy may benefit.
SGB Inc., a local agricultural biotech company, has closed an $11 million Series C financing round to help drive the commercial roll out of its hybrid crops — a low-cost and sustainable plant-based option for fuel, energy-producing biomass and protein in animal feed.
Drug developer Lpath is selling $12.5 million of stock in a direct offering.